Day: March 30, 2021

FARMINGDALE, N.Y., March 30, 2021 (GLOBE NEWSWIRE) — Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced today that it has expanded its capabilities to address the orthoplastics market by incorporating its recently introduced Sequel line of external fixators to complement its existing wound debridement and regenerative products portfolio. Stavros Vizirgianakis, president and CEO of Misonix, stated, “We have been hard at work to strategically leverage neXus, our ultrasonic platform technology and create innovative procedural solutions in high incident rate disease states. We now have a compelling suite of complementary products centered around the Misonix SonicOne® wound debridement system,...

Topline data on schedule for Q2 2021 Dermatomyositis is a rare and life-threatening autoimmune disease characterized by skin and muscle inflammation, and affects ~80,000 people in North America, EU, and Japan There is a significant need for safer and more effective treatments in dermatomyositis because of limitations of current treatment optionsNorwood, MA, March 30, 2021 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced that the last subject completed the final visit in the double-blind, placebo-controlled part of the Company’s Phase 3 DETERMINE study of lenabasum for the treatment of dermatomyositis. The open-label extension of the study is ongoing....

NEW YORK and BOULDER, Colo., March 30, 2021 (GLOBE NEWSWIRE) — Logiq, Inc. (OTCQX: LGIQ), a global provider of award-winning e-commerce and fintech solutions, has acquired Rebel AI, an innovator in digital marketing solutions. The Rebel AI platform, which is to be named Logiq Digital Marketing, will enable small and medium-sized businesses (SMB) to more effectively compete against larger businesses for new customers. Through a simplified, easy-to-use platform, marketers will be able to advertise across popular websites and connected TV media destinations to attract more consumers to their online stores. Coupled with advanced audience targeting, artificial intelligence algorithms and blockchain-based security, this platform will also lower the costs of customer acquisition. “Rebel AI’s approach to addressing the needs of e-commerce...

TORONTO, March 30, 2021 (GLOBE NEWSWIRE) — Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or “the Company”) is pleased to announce a mine life extension and updated Mineral Resource and Mineral Reserve estimate for the Chelopech mine in Bulgaria. The Mineral Resource and Mineral Reserve estimates for DPM’s Ada Tepe mine in Bulgaria and Timok gold project in Serbia remain unchanged from the estimates previously reported in the news releases dated October 16, 2020 and February 23, 2021, respectively. Highlights10% net addition to Mineral Reserves: Successfully added 3.9 million tonnes (“Mt”) to Mineral Reserves, which more than offset 2020 production depletion of 2.2 Mt for a net addition of 1.7 Mt. Relative to the previous Mineral Reserve estimate, this represents an increase of 10% in tonnage and an increase in metal content of...

The Annual General Meeting of Shareholders (AGM) of Lundin Energy AB (Lundin Energy or the Company) was held online today, Tuesday 30 March 2021. As a consequence of the global COVID-19 pandemic, the Board of Directors decided to hold the Annual General Meeting as a virtual meeting combined with an option to vote by post in advance of the Annual General Meeting in accordance with the Swedish Act on Temporary Exemptions to Facilitate the Execution of General Meetings in Companies and Associations (SFS 2020:198). The Company’s and the Group’s income statements and balance sheets for the financial year 2020, were adopted and the members of the Board of Directors and the Chief Executive Officer were discharged from liability for the financial year 2020. The AGM resolved that a dividend for the 2020 financial year in the amount...

Årsstämma i Lundin Energy AB (Lundin Energy eller bolaget) hölls idag, tisdagen den 30 mars 2021, online. Med anledning av den globala COVID-19-pandemin beslutade styrelsen att hålla årsstämman online, kombinerat med möjligheten att poströsta på förhand, i enlighet med lagen (SFS 2020:198) om tillfälliga undantag för att underlätta genomförandet av bolags- och föreningsstämmor. Moderbolagets och koncernens resultat- och balansräkningar för räkenskapsåret 2020 fastställdes och styrelsen samt verkställande direktören beviljades ansvarsfrihet för räkenskapsåret 2020. Årsstämman beslutade att en utdelning om 1,80 USD per aktie ska utgå för räkenskapsåret 2020, att utbetalas i kvartalsvisa delbetalningar. Före varje utbetalningstillfälle, kommer den kvartalsvisa utdelningen om 0,45 USD per aktie att omvandlas till ett belopp i SEK baserat...

TORONTO, March 30, 2021 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it received approval from the Turkish Ministry of Health, Pharmaceuticals and Medical Devices Agency (MoH) to recruit up to twenty additional patients into the Phase II trial of its lead drug LSALT peptide (Metablok), targeting acute lung injury and acute kidney injury caused by inflammation in patients with severe cases of COVID-19. The approval from the MoH doubles the number of patients allowed into the Turkish arm of the trial from twenty to forty. The first twenty patients in Turkey have already been recruited into the trial and have completed treatment. Patient recruitment is expected to resume this week in two hospital sites in Istanbul and Ankara. Recent data have shown a second...

This is a press release by Kiadis Pharma N.V. (“Kiadis”) in connection with the public offer by Sanofi Foreign Participations B.V. (“the Offeror”), a wholly owned subsidiary of Sanofi (“Sanofi”), for all the issued and outstanding ordinary shares in the capital of Kiadis launched on February 12, 2021 (the “Offer”). This announcement does not constitute an offer, or any solicitation of any offer, to buy or subscribe for any securities. Any offer will be made only by means of the offer memorandum approved by the Dutch Authority for the Financial Markets (Autoriteit Financiële Markten) on February 10, 2021 and recognized by the Belgian Authority for the Financial Markets (Autoriteit voor Financiële Diensten en Markten) on February 11, 2021 (the “Offer Memorandum”). This announcement is not for release, publication or distribution, in whole...